EUCTR2021-005124-38-ES进行中(未招募)1 期
Conditioned Autologous Serum Therapy (Orthokine) on the dorsal root ganglion in patients with chronic radiculalgia (RADISAC) - RADISAC
DARYD0 个研究点目标入组 50 人开始时间: 2021年11月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients older than 18 years, not illiterate, with lower limb radicular pain of more than 6 months.
- •Unilateral, mono and / or bisegmental radicular pain of a lower limb lasting at least more than 6 months.
- •In case of having received treatment previously, at least 3 months must have passed since the last therapy received (infiltration, radiofrequency or surgery) and the pain persist in the same territory.
- •Present lumbar Nuclear Magnetic Resonance (NMR), Electromyography (EMG) done concomitantly to the pain that the patient presents at the time of inclusion in the study.
- •Present a score greater than 5 in the DN4 questionnaire at the time of inclusion in the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •exclusion criteria:
- •Refusal of the patient to participate in the study or not to sign the informed consent
- •Allergy to intravenous iodinated contrast and / or local anesthetics.
- •Impossibility of the patient to maintain the prone position.
- •Systemic or local infection at the puncture site.
- •Present any of the following symptoms: atypical radiation pattern, bilateral involvement, involvement of more than two segments or roots.
- •Concomitant pathological history during study / therapy: oncological disease, vertebral fractures, myelopathy, systemic disease, connective tissue disease, coagulation disorder, multiple sclerosis, osteomyelitis, or bone edema.
- •Pregnancy or breastfeeding
- •Previous treatment with spinal neurostimulator placement
- •Previous treatment with brain stimulator for treatment of epilepsy or Parkinson's disease.
- •Cardiac pacemaker carrier.
- •Patient who does not attend any of the treatment sessions for unjustified reasons.
研究者
相似试验
已完成
不适用
Autologous conditioned serum (Orthokine®) compared with hyaluronic acid and placebo injections for the treatment of osteoarthritis. A prospective, randomized, placebo-controlled, double-blind, parallel-design, multicenter trial.Osteoarthitis of the knee.Musculoskeletal DiseasesOsteoarthritisISRCTN71311752Orthogen (Germany)400
已完成
3 期
Camparison Effects of Autologous Conditioned Serum, platelet rich plasma and Prolotherapy in treatment of Knee osteoarthritisOsteoarthritis of kneeIRCT20100720004422N6Tabriz University of Medical Sciences90
招募中
4 期
sefulness and safety of conventional and modified self-serum therapy in long standing generalised itch and wheals of skiCTRI/2016/05/006907Medical College Kolkata64
招募中
2 期
Treatment of chronic knee osteoarthritis with Autologous Conditioned SerumOsteoarthritis.Erosive (osteo)arthritisM15.4IRCT20160422027520N13Pishtaz teb zaman Co.15
已完成
不适用
Efficacy and safety of autologous conditioned serum (ACS/Orthokine®) compared with Triamcinolone in the treatment of symptomatic hip osteoarthritis.Osteoarthritis of the hipMusculoskeletal DiseasesCoxarthrosisISRCTN16719506Orthogen AG (Germany)130
